Data | Hora | Fonte | Título | Código | Companhia |
14/02/2014 | 14:35 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
16/10/2013 | 20:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
14/10/2013 | 17:30 | GlobeNewswire Inc. | Astex Pharmaceuticals to Present at AACR-NCI-EORTC | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
11/10/2013 | 15:05 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
11/10/2013 | 10:17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
11/10/2013 | 09:37 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
11/10/2013 | 09:30 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
11/10/2013 | 09:23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
09/10/2013 | 23:37 | GlobeNewswire Inc. | Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
09/10/2013 | 18:27 | PR Newswire (US) | Sarissa Capital Highlights Advancement Of Astex Pipeline Compound | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
09/10/2013 | 17:49 | PR Newswire (US) | Sarissa Capital Highlights Advancement Ofastex Pipeline Compound | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
08/10/2013 | 14:33 | PR Newswire (US) | Sarissa Capital Urges All Shareholders Of Astex Pharmaceuticals To Not Tender Their Shares At Current $8.50 Price | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
08/10/2013 | 13:27 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
07/10/2013 | 07:00 | GlobeNewswire Inc. | Astex Pharmaceuticals Announces Expiration of HSR Waiting Period for Pending Transaction | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
02/10/2013 | 20:40 | GlobeNewswire Inc. | Astex Pharmaceuticals Issues Open Letter to Stockholders Regarding Otsuka Transaction | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
02/10/2013 | 11:58 | PR Newswire (US) | Sarissa Capital Issues Open Letter Regarding Astex Pharmaceuticals | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
30/09/2013 | 07:00 | GlobeNewswire Inc. | Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
13/09/2013 | 08:37 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
09/09/2013 | 13:12 | Business Wire | Astex Pharmaceuticals, Inc. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduci... | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
09/09/2013 | 13:01 | Business Wire | Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Astex Pharmaceuticals, Inc. Shareholders | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
06/09/2013 | 19:45 | GlobeNewswire Inc. | Astex Pharmaceuticals Withdraws From Upcoming Investor Conferences | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
06/09/2013 | 19:00 | PR Newswire (US) | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc. | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
06/09/2013 | 13:36 | Business Wire | M & A Attorneys At Rigrodsky & Long, P.A. Announce Investigation Of Possible Inadequately Priced Astex Pharmaceuticals, Inc. ... | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
05/09/2013 | 22:33 | PR Newswire (US) | Acquisition of Astex Pharmaceuticals, Inc. by Otsuka Pharmaceutical Co., Ltd. May Not Be in the Best Interests of Astex Pharm... | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
05/09/2013 | 18:58 | PR Newswire (US) | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Ast... | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
05/09/2013 | 15:36 | Business Wire | Law Offices of Howard G. Smith Announces Investigation of Astex Pharmaceuticals, Inc. | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
05/09/2013 | 15:09 | Business Wire | Law Firm Brower Piven Announces Investigation of Astex Pharmaceuticals, Inc. Proposed Acquisition | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
05/09/2013 | 13:54 | Business Wire | Astex Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Acquisition by Ot... | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
05/09/2013 | 13:50 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Astex Pharmaceuticals Inc. | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
05/09/2013 | 12:28 | Business Wire | Komlossy Law, P.A. Announces Investigation of Astex Pharmaceuticals, Inc. | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |